Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Microfluidic Platforms For Malaria Detection


技术优势

This invention represents a much lower-cost and convenient alternative while offering the potential to match the sensitivity of PCR-based approach. It does not require experienced specialists as is the case for Giemsa-stained method. It has the potential to exceed the performance and accuracy of Traveler’s kits.


技术应用

This is a microfluidic platform invented for the purpose of detecting malaria infection in blood samples.


详细技术说明

Among current approaches in malaria diagnoses, those based on polymerase chain reaction (PCR) provide the highest sensitivity at 0.004 to 5 parasites per ul of blood. However, the most common PCR instruments are not portable and, therefore, inaccessible in most rural regions. Giemsa-stained thick and thin blood films are the most sensitive and specific methods available besides PCR. It exhibits sensitivities between 5 to 20 parasites per ul of blood (0.0001% parasitaemia). However, it requires a carefully prepared sample examined by a specialist, in which malaria infected red blood cells are identified from 100 to 200 microscopic fields under 1000X magnifications. Traveler’s kits, like ICT Malaria Pf/Pv®, Parasight®-F, and OptiMAL®, provide travelers rapid and portable tool to perform self-tests in the field. However, they are limited in sensitivity and specificity and, therefore, inadequate for early-stage malaria detection. What we have developed is a microfluidic platform invented for the purpose of detecting malaria infection in blood samples. The key innovation is the novel use of microfluidic technology that differentiates and immobilizes malaria infected red blood cells. It is based on the fundamental principle that malaria infected red blood cells flow differently than non-infected red blood cells. Because of this characteristic of the infected red blood cells, they can be differentiated and immobilized. Our experiments demonstrated that we can adjust parameters in the microfluidic technology so as to only immobilize malaria infected red blood cells. We can then examine the device and can determine the presence and quantity/degree of malaria infection in the blood sample. The optical detection of immobilized red blood cell can be automated using sensors, eliminating the need for human labor.


申请号码

8628972


其他

Tech ID/UC Case

21078/2010-603-0


Related Cases

2010-603-0


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版